Natera (NTRA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
1 Jul, 2026Opening remarks and agenda
Executive Chairman welcomed attendees, acknowledged presence of independent accountants and counsel, and outlined the meeting agenda including voting on five proposals.
Voting procedures and instructions for stockholders were explained, including how to submit or change votes via the virtual portal.
Board and executive committee updates
Election of three Class II directors for a three-year term and one Class I director for a two-year term was on the agenda, with all nominees unanimously recommended by the board.
Shareholder proposals
Five proposals were presented: election of directors, ratification of the independent auditor, advisory approval of executive compensation, advisory vote on frequency of compensation votes, and amendment to the 2015 Equity Incentive Plan.
The board unanimously recommended approval of all proposals.
Latest events from Natera
- Record growth, expanding global reach, and innovation drive strong financial and operational results.NTRA
2026 Global Healthcare Conference - Record MRD growth, expanding biopharma ties, and innovation set the stage for sustained expansion.NTRA
Morgan Stanley 24th Annual Global Healthcare Conference - Record Q2 growth, product innovation, and global expansion drive strong outlook.NTRA
Canaccord Genuity's 46th Annual Growth Conference - Revenue up 38% to $753M, record test volumes, improved margins, and raised guidance.NTRA
Q2 2026 - Record growth, innovation, and AI-driven strategies are accelerating adoption and market expansion.NTRA
Morgan Stanley 23rd Annual Global Healthcare Conference - Q3 2024 revenue up 64%, margin at 62%, net loss narrows, and outlook raised.NTRA
Q3 2024 - Q1 2025 revenue up 37% to $502M, record oncology growth, margin at 63.1%, net loss steady.NTRA
Q1 2025 - Record growth, innovation, and clinical momentum set the stage for major milestones in 2025.NTRA
43rd Annual J.P. Morgan Healthcare Conference 2025 - Q4 revenue up 53% to $476M, with 2025 guidance for 24% growth and margin expansion.NTRA
Q4 2024